Portfolio
Engineering Novel CAR T Cells for AML: Translating Lessons from Correlative Studies and Other Diseases
Damon Runyon - Mark Foundation Physician-Scientist (2022-Present)
Mark Leick, MD, Massachusetts General Hospital
Development of a Targeted Epigenome Modification Platform
Momentum Fellow (2022-present)
Anand Divakaran, PhD, University of California, Berkeley
Next Generation Organoids: Towards Understanding Cellular Crosstalk in Metastatic Cancer
Momentum Fellow (2022-present)
Anna-Marie Finger, PhD, University of California, San Francisco
Genomic Characterization of Recurrent High-Risk Neuroblastoma
Momentum Fellow (2022-present)
Kevin Ying, PhD, The Research Institute at Nationwide Children’s Hospital
Elucidating the Effects of Inflammation and Aging on Clonal Hematopoiesis
Momentum Fellow (2022-present)
Inés Fernández Maestre, PhD, Memorial Sloan Kettering Cancer Center
Investigating the Bacterial Microbiome in Brain Metastasis
ASPIRE Award (2022-Present)
Johanna Joyce, PhD, University of Lausanne and Ludwig Institute for Cancer Research Lausanne Branch (Switzerland)
Circulating Tumor DNA to Serially Assess in vivo Transcriptional Evolution in Cancers
ASPIRE Award (2022-Present)
Sarah-Jane Dawson, MD, PhD, Peter MacCallum Cancer Centre, The University of Melbourne (Australia)
Hijacking Immune-Cell Specific E3 Ligases for Targeted Protein Degradation
ASPIRE Award (2022-Present)
Georg Winter, PhD, CeMM- Research Center for Molecular Medicine (Austria); Steve Gygi, PhD, Harvard Medical School
Harnessing Induced Proximity to Expand Cancer Therapeutic Modalities
ASPIRE Award (2022-Present)
Mikko Taipale, PhD, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto; Daniel Durocher, PhD, Frank Sicheri, PhD, Mount Sinai Hospital (Canada)
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you agree to our Terms of Use and Privacy Policy.OkPrivacy Policy and Terms of Use
